-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Veradermics, Raises Price Target to $175

Benzinga·11/10/2026 19:32:05
Listen to the news
Citigroup analyst Geoff Meacham maintains Veradermics (NYSE:MANE) with a Buy and raises the price target from $160 to $175.